BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12135235)

  • 1. A study on latency in calves by five vaccines against bovine herpesvirus-1 infection.
    Castrucci G; Frigeri F; Salvatori D; Ferrari M; Dico ML; Rotola A; Sardonini Q; Petrini S; Cassai E
    Comp Immunol Microbiol Infect Dis; 2002 Jul; 25(4):205-15. PubMed ID: 12135235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies.
    Lemaire M; Schynts F; Meyer G; Georgin JP; Baranowski E; Gabriel A; Ros C; Belák S; Thiry E
    Vaccine; 2001 Sep; 19(32):4795-804. PubMed ID: 11535332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
    Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
    Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination of calves against bovine herpesvirus-1: assessment of the protective value of eight vaccines.
    Castrucci G; Frigeri F; Salvatori D; Ferrari M; Sardonini Q; Cassai E; Lo DM; Rotola A; Angelini R
    Comp Immunol Microbiol Infect Dis; 2002 Jan; 25(1):29-41. PubMed ID: 11831745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No vaccine interference between bovine coronavirus and bovine herpesvirus-1 in a randomized trial when coadministrating two intranasal modified-live viral vaccines to neonatal calves.
    Bolton MW; Nordstrom S; Hill K; Midla L; Rajamanikam K; Griebel PJ
    Am J Vet Res; 2024 May; 85(5):. PubMed ID: 38457927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant virus-expressed bovine cytokines do not improve efficacy of a bovine herpesvirus 1 marker vaccine strain.
    König P; Beer M; Makoschey B; Teifke JP; Polster U; Giesow K; Keil GM
    Vaccine; 2003 Dec; 22(2):202-12. PubMed ID: 14615147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longevity of protective immunity to experimental bovine herpesvirus-1 infection following inoculation with a combination modified-live virus vaccine in beef calves.
    Ellis J; Waldner C; Rhodes C; Ricketts V
    J Am Vet Med Assoc; 2005 Jul; 227(1):123-8. PubMed ID: 16013547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine.
    Campos FS; Dezen D; Antunes DA; Santos HF; Arantes TS; Cenci A; Gomes F; Lima FE; Brito WM; Filho HC; Batista HB; Spilki FR; Franco AC; Rijsewijk FA; Roehe PM
    Vet Microbiol; 2011 Feb; 148(1):18-26. PubMed ID: 20828945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid onset of protection following vaccination of calves with multivalent vaccines containing modified-live or modified-live and killed BHV-1 is associated with virus-specific interferon gamma production.
    Woolums AR; Siger L; Johnson S; Gallo G; Conlon J
    Vaccine; 2003 Mar; 21(11-12):1158-64. PubMed ID: 12559793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization against bovine herpesvirus-1 infection. Preliminary tests in calves with a DNA vaccine.
    Castrucci G; Ferrari M; Marchini C; Salvatori D; Provinciali M; Tosini A; Petrini S; Sardonini Q; Lo Dico M; Frigeri F; Amici A
    Comp Immunol Microbiol Infect Dis; 2004 May; 27(3):171-9. PubMed ID: 15001312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene.
    Kaashoek MJ; Rijsewijk FA; Ruuls RC; Keil GM; Thiry E; Pastoret PP; Van Oirschot JT
    Vaccine; 1998 May; 16(8):802-9. PubMed ID: 9627937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine.
    Kaashoek MJ; Moerman A; Madić J; Rijsewijk FA; Quak J; Gielkens AL; van Oirschot JT
    Vaccine; 1994 Apr; 12(5):439-44. PubMed ID: 8023552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of latency associated with glycoprotein E (gE) seroconversion after bovine herpesvirus 1 infection in calves with high levels of passive antibodies lacking gE antibodies.
    Schynts F; Lemaire M; Ros C; Belak S; Thiry E
    Vet Microbiol; 2001 Sep; 82(3):211-22. PubMed ID: 11470543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One year duration of immunity of the modified live bovine viral diarrhea virus type 1 and type 2 and bovine herpesvirus-1 fractions of Vista® Once SQ vaccine.
    Purtle L; Mattick D; Schneider C; Smith L; Xue W; Trigo E
    Vaccine; 2016 Mar; 34(13):1582-1588. PubMed ID: 26859238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of bovine herpesvirus type 1-seronegative latent carriers by administration of a live-attenuated vaccine in passively immunized calves.
    Lemaire M; Meyer G; Baranowski E; Schynts F; Wellemans G; Kerkhofs P; Thiry E
    J Clin Microbiol; 2000 Nov; 38(11):4233-8. PubMed ID: 11060097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latency-related gene encoded by bovine herpesvirus 1 promotes virus growth and reactivation from latency in tonsils of infected calves.
    Perez S; Inman M; Doster A; Jones C
    J Clin Microbiol; 2005 Jan; 43(1):393-401. PubMed ID: 15635000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice.
    Caselli E; Boni M; Di Luca D; Salvatori D; Vita A; Cassai E
    Comp Immunol Microbiol Infect Dis; 2005 Mar; 28(2):155-66. PubMed ID: 15582691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of immune responses in cattle with a DNA vaccine encoding glycoprotein C of bovine herpesvirus-1.
    Gupta PK; Saini M; Gupta LK; Rao VD; Bandyopadhyay SK; Butchaiah G; Garg GK; Garg SK
    Vet Microbiol; 2001 Feb; 78(4):293-305. PubMed ID: 11182496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the biology of bovine herpesvirus type 1 (BHV-1), its role as a cofactor in the bovine respiratory disease complex and development of improved vaccines.
    Jones C; Chowdhury S
    Anim Health Res Rev; 2007 Dec; 8(2):187-205. PubMed ID: 18218160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mutation in the latency-related gene of bovine herpesvirus 1 disrupts the latency reactivation cycle in calves.
    Inman M; Lovato L; Doster A; Jones C
    J Virol; 2002 Jul; 76(13):6771-9. PubMed ID: 12050390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.